Association of HLA Class II Alleles and Haplotypes with Type 1 Diabetes in Tunisian Arabs

Abdelhafidh Hajjej; Wassim Y. Almawi; Mouna Stayoussef; Lasmar Hattab; Slama Hmida

doi:10.1055/a-0754-5586

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2019; 127(10): 653-662
DOI: 10.1055/a-0754-5586

Article

Association of HLA Class II Alleles and Haplotypes with Type 1 Diabetes in Tunisian Arabs

Authors

Abdelhafidh Hajjej

¹Department of Immunogenetics, National Blood Transfusion Center, Tunis, Tunisia
Wassim Y. Almawi

²School of Pharmacy, Lebanese American University, Byblos, Lebanon

³Department of Biological Sciences, Faculty of Sciences, El-Manar University, Tunis, Tunisia
Mouna Stayoussef

³Department of Biological Sciences, Faculty of Sciences, El-Manar University, Tunis, Tunisia
Lasmar Hattab

⁴Department of Medical Analysis, Regional Hospital of Gabes (Ghannouch), Gabes, Tunisia
Slama Hmida

¹Department of Immunogenetics, National Blood Transfusion Center, Tunis, Tunisia

Abstract

The molecular association of HLA class II with type 1 diabetes (T1DM) was investigated in Tunisian Arabs using 3 kinds of analyses. The first was a case-control association study, using Relative Predispositional Effects method, involved 137 T1DM cases and 258 control subjects. The second was family-based association-linkage study, using Transmission Disequilibrium Test, and covering 50 Tunisian families comprising 73 T1DM patients and 100 parents. The third was a wide correlation study between 4 DRB1 alleles (DRB1*03, *04, *11, *15) and T1DM in 52 countries, using Spearman’s Rho. Results from Case-control and family-based association studies showed that DRB1*03 and DRB1*04 alleles predispose to T1DM in Tunisian Arabs. Conversely, only DRB1*11 was protective for T1DM. DRB1*04-DQB1*03 haplotype was consistently associated positively with T1DM; DRB1*03/DRB1*04 genotype had the highest risk of T1DM development. Compared to DRB1*03, HLA-DRB1*04 was associated with higher T1DM incidence. Thus, the contribution of HLA class II to T1DM genetic susceptibility must be evaluated with regards to specific HLA alleles, genotypes, and haplotypes, and also ethnic and racial background.

Key words

Type 1 diabetes - case-control - HLA - correlation - Tunisian

Full Text

References

References
1 Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360: 1646-1654
2 Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010; 32: 468-478
3 Froguel P. Genetics of type 1 insulin-dependent diabetes mellitus. Horm Res. 1997; 48: 55-57
4 HLA database http://hla.alleles.org/nomenclature/index.html 2016; (accessed 28.11.16)
5 Robinson J, Soormally AR, Hayhurst JD. et al. The IPD-IMGT/HLA Database -New developments in reporting HLA variation. Hum Immunol. 2016; 77: 233-237
6 Marrack P, Kappler J. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. Adv Immunol. 1986; 38: 1-30
7 Marrack P, Bender J, Jordan M. et al. Major histocompatibility complex proteins and TCRs: Do they really go together like a horse and carriage?. J Immunol 2001; 167: 617-621
8 Nerup J, Christy M. Green et al. HLA and insulin dependent diabetes-population studies. Serono Symposium N° 47, ″ the genetics of diabetes mellitus″. Köbberling J. ed and Tattersall. R London and New York: Academic Press; 1982
9 Bach JF. Mechanism of autoimmunity in insulin-dependant diabetes mellitus. Clin. Exp-immunol 1988; 72: 1-8
10 Katsarou A, Gudbjörnsdottir S, Rawshani A. et al. Type 1 diabetes mellitus. Nat Rev Dis Primers 2017; 3: 17016
11 Ayed K, Bardi R, Gorgi Y. et al. HLA- A, B, C and DR antigens and complotypes in tunisians patients with diabetes mellitus. Disease markers 1989; 47: 23-28
12 Jenhani F, Bardi R, Gorgi Y. et al. Polymorphisme HLA-A, B, C, DR, C4, Bf chez les diabétiques insulino- dépendant dans la population tunisienne. Ann. Biol. Clin. 1989; 47: 23-28
13 Abid Kamoun H, Hmida S, Kaabi H. et al. HLA polymorphism in type 1 diabetes tunisians. Ann Genet. 2002; 45: 45-50
14 Stayoussef M, Benmansour J, Al-Irhayim AQ. et al. Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia. Clin Vaccine Immunol 2009; 16: 1146-1150
15 Fekih Mrissa N, Mrad M, Ouertani H. et al. Association of HLA-DR-DQ polymorphisms with diabetes in tunisian patients. Transfus Apher Sci 2013; 49: 200-204
16 Miller SA, Dykes DD, Polesky HF. A sample salting out procedure for extraction DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215-1218
17 Buyse I, Decorte R, Baens M. et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993; 41: 1-14
18 Hmida S, Gauthier A, Dridi A. et al. HLA class II gene polymorphism in Tunisians. Tissue Antigens 1995; 45: 63-68
19 Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. 1995; 12: 921-927
20 Schneider S, Kueffer JM. Roessli et al. Arlequin: A Software Environment for the Analysis of Population Genetics Data. Geneva, Switzerland: Genetics and Biometry Lab; 1996
21 Lancaster AK, Nelson MP, Single RM. et al. PyPop: A software framework for population genomics: analyzing large-scale multi-locus genotype data. In: Altman RB, Dunker K, Hunter L, Jung T, Klein T. (editors.) Pacific Symposium on Biocomputing 8. Singapore: World Scientific; 2003: 514-525
22 Lancaster AK, Single RM, Solberg OD. et al. PyPop update - a software pipeline for large-scale multilocus population genomics. Tissue Antigens 2007; 69: 192-197
23 Falk CT, Rubinstein P. Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987; 51: 227-233
24 Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982; 116: 547-553
25 Schmidt CO, Kohlmann T. When to use the odds ratio or the relative risk?. Int J Public Health 2008; 53: 165-167
26 Payami H, Joe S, Farid NR. et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA- DR alleles and graves disease. Am J. Hum. Genet. 1989; 45: 541-546
27 Spielman RS, Mc Ginnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993; 52: 506-516
28 Spielman RS. Genes for autoimmune disease genetics of type 1 diabetes as a paradigm. Eighth international symposium on coelliac disease 1999; 21-24
29 Rubinstein P, Walker M, Carpenter C. et al. Genetics of HLA disease associations. The use of the haplotype relative risk (HRR) and the “haplo-delta’’ (Dh) estimates in juvenile diabetes from three racial groups. Hum Immunol. 1981; 3: 384
30 Glantz SA. Primer of biostatistics. Seventh edition New York: McGraw-Hill; 2012
31 Hajjej A, Kâabi H, Sellami MH. et al. The contribution of HLA class I and II alleles and haplotypes to the investigation of the evolutionary history of Tunisians. Tissue Antigens 2006; 68: 153-162
32 Hajjej A, Almawi WY, Hattab L. et al. HLA Class I and Class II Alleles and Haplotypes Confirm the Berber Origin of the Present Day Tunisian Population. PLoS One 2015; 10: e0136909
33 Hajjej A, Almawi WY, Hattab L. et al. The investigation of the origin of southern tunisians using HLA genes. J Hum Genet 2017; 62: 419-429
34 Djoulah S, Khalil I, Beressi JP. et al. The HLA-DRB1⁄0405 haplotype is most strongly associated with IDDM in Algerians. Eur J Immunogenet 1992; 19: 381-389
35 Aribi M, Moulessehoul S, Benabadji AB. et al. HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen. BMC Genet. 2004; 5: 24
36 Izaabel H, Garchon HJ, Beaurain G. et al. Distribution of HLA class II alleles and haplotypes in insulin-dependent Moroccan diabetics. Hum Immunol. 1996; 49: 137-143
37 Drissi Bourhanbour A, Benseffaj N, Ouadghiri S. et al. Family-based association study of HLA class II with type 1 diabetes in Moroccans. Pathol Biol (Paris) 2015; 63: 80-84
38 Thomas L. Retrospective power analysis. Conservation Biology 1997; 11: 276-280
39 Hoenig JM, Heisey DM. The abuse of power: The pervasive fallacy of power calculations for data analysis. The American Statistician 2001; 55: 1-6
40 Caillat-Zucman S, Djilali-Saiah I. Timsit et al. Insulin dependent diabetes mellitus (IDDM). In genetic diversity of HLA functional and medical implications. (ed.). charron. D 1997; volume II: 389-398
41 Hamzeh AR, Nair P, Al-Khaja N. et al. Association of HLA-DQA1 and -DQB1 alleles with type I diabetes in Arabs: a meta-analyses. Tissue Antigens 2015; 86: 21-27
42 Hamzeh AR, Nair P, Al Ali MT. The profile of HLA-DRB1 alleles in arabs with type 1 diabetes; meta-analyses. HLA 2016; 87: 25-30
43 Thomson G, Robinson WP, Kuhner MK. et al. Genetic heterogeneity, Modes of inheritance, and risk estimates for a joint study of caucasians with insulin dependent diabetes mellitus. A.M.J. Hum. Genet 1988; 43: 799-816
44 Miyadera H, Tokunaga K. Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism. J Hum Genet 2015; 60: 697-702
45 van Lummel M, van Veelen PA, de Ru AH. et al. Discovery of a selective islet peptidome presented by the highest-risk hla-dq8trans molecule. Diabetes. 2016; 65: 732-741
46 Yang J, Chow IT, Sosinowski T. et al. Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes. Proc Natl Acad Sci USA 2014; 111: 14840-14845
47 Sheehy MJ. HLA and insulin-dependent diabetes. A protective perspective. Diabetes. 1992; 41: 123-129
48 Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987; 329: 599-604
49 Todd JA. Genetics of type 1 diabetes. Pathol Biol (Paris) 1997; 45: 219-227

Supplementary Material

Supplementary Material (PDF)